艾力斯(688578.SH)2025年度归母净利润21.81亿元，同比增长52.55%

Core Viewpoint - The company,艾力斯, reported a significant increase in both total revenue and net profit for the fiscal year 2025, driven primarily by strong sales of its core product,甲磺酸伏美替尼片 [1] Financial Performance - The total revenue for 2025 reached 5.172 billion yuan, representing a year-on-year growth of 45.36% [1] - The net profit attributable to the parent company's shareholders was 2.181 billion yuan, showing a year-on-year increase of 52.55% [1] Product Performance - The substantial revenue growth was mainly attributed to the increased sales volume of the core product,甲磺酸伏美替尼片, which significantly boosted sales income [1]